Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients

ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-80
SponsorYonsei University

About this trial

The goal of this clinical trial is to learn whether a wearable monitoring system can help adults who have had a stroke get more out of a home exercise program. The system tracks how participants walk and move, then gives them feedback. Researchers want to know if this feedback improves walking, thinking and memory, and daily activity.

The wearable monitoring system has three parts:

A shoe insole sensor that measures how a person walks A wrist band that tracks daily activity, like a fitness watch A mobile app that gives feedback and lets participants report how they feel

The main questions this study aims to answer are:

Does feedback from the wearable system improve physical function, thinking and memory, and daily activity during a home exercise program? How satisfied are participants with using the wearable system?

Researchers will compare two groups. Both groups do the same home exercise program for 6 weeks. One group uses the wearable system and gets feedback. The other group does the program without the wearable system or feedback. This comparison shows whether the feedback itself makes a difference.

Who can take part: adults who have had a stroke and \[key eligibility in plain words, e.g., "can walk a short distance with or without help"\]. The study plans to enroll about \[number\] participants.

Participants in the wearable group will:

Get an insole sensor, a wrist activity tracker, and access to a mobile app Learn a home exercise program from the study team Wear the insole sensor and activity tracker while exercising at home for 6 weeks Use the app to see their feedback and report daily health information Complete a survey about their experience at the end

Participants in the comparison group will:

Do the same home exercise program for 6 weeks, without the wearable system or feedback.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 19 years or older and under 80 years

Persons diagnosed with cerebral infarction or intracerebral hemorrhage confirmed by magnetic resonance imaging or computed tomography

Persons for whom at least 1 month has elapsed since the diagnosis of stroke

Persons showing a spastic hemiplegic gait pattern due to stroke

Disqualifiers

Persons with contraindications to lower-extremity weight bearing, such as severe lower-extremity joint contracture or an untreated fracture

Persons for whom wearing the device is difficult due to skin disease or open wounds

Persons with a severe difference in the length of the two lower extremities

Persons with severe deformity or joint contracture in the lower extremities

Trial design

Design model

Single group

Treatments tested in this trial

  • hip-assisted wearable robot

    Device

    A hip-assisted wearable robot (wearable gait-assist robot) that assists flexion and extension of the hip joint during walking. The battery-powered device is controlled through a paired mobile application via Bluetooth, and its assistive force can be adjusted to each participant. A visiting physical or occupational therapist applies the device and delivers gait training at the participant's home for 4 sessions over 2 weeks, 30 minutes per session, under a physician's prescription and supervision.

Treatment groups

8 Participants
are divided into 1 treatment group
Group A: Intervention group (Home-based Robot-assisted Gait training group)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Telehealth Usability Questionnaire (TUQ)

Usability of the home-based robot-assisted gait rehabilitation service, measured with a questionnaire based on the Telehealth Usability Questionnaire (TUQ). Items are rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate better usability. Total and item scores are summarized.

Time frame
At the end of the 2-week intervention (after session 4)

Secondary outcomes

1

Distance of 2-Minute Walk Test (2MWT)

Patients are instructed to walk back as many times as possible within 2 minutes. The examiner records the total distance covered, abnormal gait patterns, and the time of occurrence of any gait deviations.

Time frame
Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
2

Spatiotemporal Parameters of Gait: Cadence

While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Cadence: The number of steps taken per minute, measured in steps per minute (spm).

Time frame
Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
3

Spatiotemporal Parameters of Gait : Total Step Count

While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Total Step Count: The total number of steps taken during walking.

Time frame
Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
4

Spatiotemporal Parameters of Gait : Self-Selected Walking Speed

While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Self-Selected Walking Speed: The participant's walking speed when walking naturally at a comfortable pace.

Time frame
Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yonsei University

Lead sponsor

Severance Hospital

Sponsor institution

Korea Health Industry Development Institute

Collaborator